Literature DB >> 23570031

The perils of prescribing fluoroquinolones.

Joel J Heidelbaugh1, Heather Holmstrom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570031

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  5 in total

1.  Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study.

Authors:  Dzenefa Alihodzic; Sebastian G Wicha; Otto R Frey; Christina König; Michael Baehr; Dominik Jarczak; Stefan Kluge; Claudia Langebrake
Journal:  Pharmaceutics       Date:  2022-04-29       Impact factor: 6.525

2.  Assessment of Knowledge Regarding Safety Profile, Use, and Boxed Warnings of Fluoroquinolones Among Healthcare Professionals in Saudi Arabia: A Potential Implication for Drug Regulatory Authorities.

Authors:  Tauqeer Hussain Mallhi; Abdullah Salah Alanazi; Yusra Habib Khan; Nasser Hadal Alotaibi; Muhammad Salman; Abdulaziz Ibrahim Alzarea; Salah-Ud-Din Khan; Nabil K Alruwaili; Alaa Salah Alenazi; Ahmed D Alatawi; Zafar Iqbal; Muhammad Hammad Butt; Muhammad Shahid Iqbal
Journal:  Front Med (Lausanne)       Date:  2022-04-29

Review 3.  Prescribed drugs containing nitrogen heterocycles: an overview.

Authors:  Majid M Heravi; Vahideh Zadsirjan
Journal:  RSC Adv       Date:  2020-12-15       Impact factor: 4.036

4.  Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease.

Authors:  Flory Tsobo Muanda; Manish M Sood; Matthew A Weir; Jessica M Sontrop; Fatemeh Ahmadi; Elisa Yoo; Richard B Kim; Michael S Silverman; Gregory A Knoll; Amit X Garg
Journal:  JAMA Netw Open       Date:  2022-08-01

5.  Acute Psychosis After Treatment of Epididymitis with Ciprofloxacin.

Authors:  Garrett Rossi; Kristen Mazoki
Journal:  Cureus       Date:  2018-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.